Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Efficacy of Irreversible Electroporation for the Treatment of Perivascular Liver Cancers

NCT07063771 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT07063771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07063771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Efficacy of Irreversible Electroporation for the Treatment of Perivascular Liver Cancers
Lead sponsor
National Taiwan University Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 1, 2025
Completion date
July 31, 2027
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

liver tumors